Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital

NCT: NCT03750318 · ACTIVE_NOT_RECRUITING

NCT IDNCT03750318
StatusACTIVE_NOT_RECRUITING
Start Date2019-01-31
Completion2026-12-31
SponsorKK Women's and Children's Hospital (OTHER_GOV)
First posted
Last updated

Brief Summary

This proposal describes the evaluation of a CE-marked, FDA cleared vital signs Surveillance Monitoring system within an adult in-patient setting KK Women's and Children's Hospital ("KKH"), the main tertiary women and children hospital in Singapore. User acceptance of Aingeal and the Surveillance System will be considered within the clinical settings.

Frequently Asked Questions

What is Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital?

Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital is a clinical trial registered under NCT03750318. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03750318?

The current status of NCT03750318 (Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital) is: ACTIVE_NOT_RECRUITING.

When did Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital start?

Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital started on 2019-01-31.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.